San Clemente, CA, United States of America

Steven L Krill

USPTO Granted Patents = 17 (Patent Applications = 21)

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Chatham, NJ (US) (2008)
Gurnee, IL (US) (2000 - 2015)
San Clemente, CA (US) (2021 - 2023)
Midland Park, NJ (US) (2023)

Company Filing History:

Eagle Pharmaceuticals, Inc.

patents

3 out of 4,179

Abbott Laboratories Corporation

Years Active: 2000-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12397006 - Fospropofol formulations (2025-08-26),

2. 12377110 - Fospropofol methods and compositions (2025-08-05),

3. 12370199 - Fulvestrant formulations and methods of their use (2025-07-29),

4. 12364704 - Fospropofol salts, methods and compositions (2025-07-22),

5. 12186427 - Fulvestrant formulations and methods of their use (2025-01-07),

6. 12115164 - Pemetrexed formulations (2024-10-15),

7. 11793813 - Pemetrexed formulations (2023-10-24),

8. 11628178 - Fospropofol methods and compositions (2023-04-18),

9. 11590077 - Fulvestrant formulations and methods of their use (2023-02-28),

10. 11547714 - Fospropofol salts, methods and compositions (2023-01-10),

11. 11478490 - Fospropofol formulations (2022-10-25),

12. 11439653 - Fospropofol formulations (2022-09-13),

13. 11207334 - Fospropofol formulations (2021-12-28),

14. 9107830 - Inhibitors of crystallization in a solid dispersion (2015-08-18),

15. 7364752 - Solid dispersion pharamaceutical formulations (2008-04-29),

Title: The Innovative Contributions of Steven L. Krill

Introduction

Steven L. Krill is an accomplished inventor based in San Clemente, California. With an impressive portfolio of seven patents, he has made significant contributions to the field of pharmaceutical formulations. His work demonstrates a strong commitment to advancing medical technology and improving patient care.

Latest Patents

Krill's most recent patents include innovative formulations of pemetrexed, designed to ensure stability after dilution at controlled temperatures. One notable invention involves a pemetrexed formulation that remains stable for at least 48 hours when stored at 2°C to 8°C, and another that guarantees stability for up to 24 months under the same conditions. Additionally, he has developed methods and compositions involving fospropofol, which address various diseases and disorders, including migraine-related conditions. These advancements highlight his dedication to enhancing pharmacological efficacy and safety.

Career Highlights

Steven Krill has worked with notable companies including Epalex Corporation and Eagle Pharmaceuticals, Inc. Throughout his career, he has focused on innovative solutions that push the boundaries of pharmaceutical science. His expertise in formulating drugs contributes to new treatment options for patients, showcasing his impactful role in the industry.

Collaborations

During his career, Krill has collaborated with prominent professionals such as Feng-Jing Chen and Randall B. Murphy. These partnerships have further enriched his research and development efforts, leading to advancements in the pharmaceutical sector.

Conclusion

Steven L. Krill's innovative spirit and commitment to pharmaceutical enhancements mark him as a vital contributor to modern medicine. With his notable patents and collaborations, he continues to play an essential role in improving therapeutic options for patients worldwide. His work exemplifies the power of innovation in driving the healthcare industry forward.

This text is generated by artificial intelligence and may not be accurate.